Beyfortus is the first preventive option approved to protect a broad infant population, including those born healthy at term, preterm, or with specific health conditions that make them vulnerable to severe RSV disease.
There is a slightly elevated risk of intracranial thrombosis events following vaccination with the AstraZeneca ChAdOx1-S COVID vaccine, according to two new studies published in Plos Medicine
The combination of AstraZeneca and Pfizer vaccines produce a strong immune response to the novel coronavirus, according to new research.
“A potentially unexplained illness” in a recipient of AstraZeneca’s COVID-19 vaccine candidate AZD1222 has halted the company’s phase 3 clinical trial, the AP reports.
Read More
The multi-site, Phase 3 clinical trial will enroll 30,000 adults in order to evaluate AstraZeneca’s investigational COVID-19 vaccine known as AZD1222.
Read More
Science Magazine investigates the latest medications that are targeting respiratory syncytial virus (RSV).
Read More
Breztri Aerosphere is a single-inhaler, fixed dose triple-combination of the ICS budesonide, the LAMA glycopyrrolate, and LABA formoterol fumarate.
Read More
The COVID-19 vaccine being developed by Oxford University and AstraZeneca led to an immune response in roughly 1,000 patients, early study results show.
Read More
Data from a late-stage trial on the cancer drug Imfinzi, in combination with chemotherapies, demonstrated improvement in survival of certain lung cancer patients, AstraZeneca Plc announced this week.
Read More
New data demonstrated that the maintenance combination asthma therapy, Symbicort (budesonide/formoterol fumarate dehydrate), provides a rapid, clinically significant bronchodilatory response.
Read More